Cargando…

The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs

The aim of the study was to verify if quantification of placental specific C19MC microRNAs in plasma exosomes would be able to differentiate during the early stages of gestation between patients subsequently developing pregnancy-related complications and women with the normal course of gestation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hromadnikova, Ilona, Dvorakova, Lenka, Kotlabova, Katerina, Krofta, Ladislav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627682/ https://www.ncbi.nlm.nih.gov/pubmed/31216670 http://dx.doi.org/10.3390/ijms20122972

Ejemplares similares

First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Circulating C19MC MicroRNAs in Preeclampsia, Gestational Hypertension, and Fetal Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2013)

Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR
por: Hromadnikova, Ilona, et al.
Publicado: (2017)

First Trimester Screening of Circulating C19MC microRNAs Can Predict Subsequent Onset of Gestational Hypertension
por: Hromadnikova, Ilona, et al.
Publicado: (2014)

Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2015)

Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Substantially Altered Expression Profile of Diabetes/Cardiovascular/Cerebrovascular Disease Associated microRNAs in Children Descending from Pregnancy Complicated by Gestational Diabetes Mellitus—One of Several Possible Reasons for an Increased Cardiovascular Risk
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Novel First-Trimester Prediction Model for Any Type of Preterm Birth Occurring before 37 Gestational Weeks in the Absence of Other Pregnancy-Related Complications Based on Cardiovascular Disease-Associated MicroRNAs and Basic Maternal Clinical Characteristics
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

First-Trimester Screening for Miscarriage or Stillbirth—Prediction Model Based on MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2023)

Maternal Cardiovascular Risk Assessment 3-to-11 Years Postpartum in Relation to Previous Occurrence of Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

First-Trimester Screening for HELLP Syndrome—Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics
por: Hromadnikova, Ilona, et al.
Publicado: (2023)

Expression profile of C19MC microRNAs in placental tissue of patients with preterm prelabor rupture of membranes and spontaneous preterm birth
por: Hromadnikova, Ilona, et al.
Publicado: (2017)

Circulating heat shock protein mRNA profile in gestational hypertension, pre-eclampsia & foetal growth restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2016)

First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Association Analysis in Young and Middle-Aged Mothers—Relation between Expression of Cardiovascular Disease Associated MicroRNAs and Abnormal Clinical Findings
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

Postnatal Expression Profile of MicroRNAs Associated with Cardiovascular Diseases in 3- to 11-Year-Old Preterm-Born Children
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

Association Analysis in Children Born from Normal and Complicated Pregnancies—Cardiovascular Disease Associated microRNAs and the Incidence of Prehypertension/Hypertension, Overweight/Obesity, Valve Problems and Heart Defects
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

Extracellular chromosome 21-derived microRNAs in euploid & aneuploid pregnancies
por: Kotlabova, Katerina, et al.
Publicado: (2013)

Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells
por: Hromadnikova, Ilona, et al.
Publicado: (2016)

Screening for Preeclampsia and Fetal Growth Restriction in the First Trimester in Women without Chronic Hypertension
por: Tousty, Piotr, et al.
Publicado: (2023)

The Effects of Prenatal Pravastatin Treatment in the Rabbit Fetal Growth Restriction Model
por: Zapletalova, Katerina, et al.
Publicado: (2023)

Association of Corpus Callosum Development With Fetal Growth Restriction and Maternal Preeclampsia or Gestational Hypertension
por: Zheng, Weizeng, et al.
Publicado: (2022)

Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy
por: Luque, Ana, et al.
Publicado: (2014)

Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of Pregnancy
por: Ogoyama, Manabu, et al.
Publicado: (2022)

Correlation of Maternal Serum Homocysteine in the First Trimester with the Development of Gestational Hypertension and Preeclampsia
por: Sun, Feng, et al.
Publicado: (2017)

Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia
por: Dobierzewska, Aneta, et al.
Publicado: (2017)

Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
por: Gong, Sungsam, et al.
Publicado: (2018)

Small RNA sequencing of exosomal microRNAs reveals differential expression of microRNAs in preeclampsia
por: Ning, Hui, et al.
Publicado: (2023)

The Role of Uterine Artery Doppler in the Second and Third Trimesters for Prediction of Preeclampsia and Fetal Growth Restriction Developed as a Consequence of Placental-Mediated Diseases
por: TUDOR, ADRIANA, et al.
Publicado: (2023)

Proteomic analysis of the umbilical cord in fetal growth restriction and preeclampsia
por: Conrad, Matthew S., et al.
Publicado: (2022)

Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth Restriction
por: Pedroso, Marianna Amaral, et al.
Publicado: (2018)

First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
por: Austdal, Marie, et al.
Publicado: (2015)

“Screening for small-for-gestational age neonates at early third trimester in a high-risk population for preeclampsia”
por: Mula, Raquel, et al.
Publicado: (2020)

Performance of Fetal Medicine Foundation algorithm for first trimester preeclampsia screening in an indigenous south Asian population
por: Prasad, Smriti, et al.
Publicado: (2021)

Differential Gene Expression at the Maternal-Fetal Interface in Preeclampsia Is Influenced by Gestational Age
por: Lian, Ingrid A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ne5lkfp2scva5jo8d44cjqmc4a